- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Attitudes toward clinical trials across the Alzheimer’s disease spectrum ; volume:9 ; number:1 ; day:4 ; month:10 ; year:2017 ; pages:1-10 ; date:12.2017
Alzheimer's research & therapy ; 9, Heft 1 (4.10.2017), 1-10, 12.2017
- Keyword
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Creator
-
Nuño, Michelle M.
- Contributor
-
Gillen, Daniel L.
Dosanjh, Kulwant K.
Brook, Jenny
Elashoff, David
Ringman, John M.
Grill, Joshua D.
SpringerLink (Online service)
- DOI
-
10.1186/s13195-017-0311-5
- URN
-
urn:nbn:de:1111-2017112945
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nuño, Michelle M.
- Gillen, Daniel L.
- Dosanjh, Kulwant K.
- Brook, Jenny
- Elashoff, David
- Ringman, John M.
- Grill, Joshua D.
- SpringerLink (Online service)
Other Objects (12)
Undergraduate nursing students’ knowledge of and attitudes toward people with alzheimer’s disease
Drug candidates in clinical trials for Alzheimer’s disease
Imaging endpoints for clinical trials in Alzheimer’s disease
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Estimating Socio-Economic Status for Alzheimer’s Disease Trials
Young-onset Alzheimer’s dementia mimicking progressive myoclonic epilepsy spectrum
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
The Role of Futility Analyses in Alzheimer’s Disease Clinical Trials
Cohort Effects in Alzheimer’s Disease Trials: An Empirical Assessment Utilizing Data from the Alzheimer’s Disease Cooperative Study
The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease
An Approach toward Artificial Intelligence Alzheimer’s Disease Diagnosis Using Brain Signals
Recruitment across two decades of NIH-funded Alzheimer’s disease clinical trials
Undergraduate nursing students’ knowledge of and attitudes toward people with alzheimer’s disease
Drug candidates in clinical trials for Alzheimer’s disease
Imaging endpoints for clinical trials in Alzheimer’s disease
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Estimating Socio-Economic Status for Alzheimer’s Disease Trials
Young-onset Alzheimer’s dementia mimicking progressive myoclonic epilepsy spectrum
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
The Role of Futility Analyses in Alzheimer’s Disease Clinical Trials
Cohort Effects in Alzheimer’s Disease Trials: An Empirical Assessment Utilizing Data from the Alzheimer’s Disease Cooperative Study
The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease
An Approach toward Artificial Intelligence Alzheimer’s Disease Diagnosis Using Brain Signals
Recruitment across two decades of NIH-funded Alzheimer’s disease clinical trials
Undergraduate nursing students’ knowledge of and attitudes toward people with alzheimer’s disease
Drug candidates in clinical trials for Alzheimer’s disease
Imaging endpoints for clinical trials in Alzheimer’s disease
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Estimating Socio-Economic Status for Alzheimer’s Disease Trials
Young-onset Alzheimer’s dementia mimicking progressive myoclonic epilepsy spectrum
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
The Role of Futility Analyses in Alzheimer’s Disease Clinical Trials
Cohort Effects in Alzheimer’s Disease Trials: An Empirical Assessment Utilizing Data from the Alzheimer’s Disease Cooperative Study
The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease
An Approach toward Artificial Intelligence Alzheimer’s Disease Diagnosis Using Brain Signals